IDDI Management of your trials during Covid-19 Pandemic
FDA and EMA recently each issued guidance on the management of clinical trials during the COVID-19 pandemic.
IDDI IS TAKING PROACTIVE STEPS TO HELP OUR CLIENTS IN THESE DIFFICULT TIMES…
Do you have ongoing trials?
IDDI’s statistical expertise can help you explore different options and methods to mitigate the effects of the current crisis on your trials.
Do you have plans to start a new trial?
IDDI can support you with expert trial design, sample-size calculations, SAPs and other services.
We can help you make sure your clinical study delivers timely and reliable results!
Get in touch and engage with IDDI experts on best practices to be followed in the current situation.
TOP REASONS TO PARTNER WITH IDDI: